Investor Relations
The investor pages that follow are your resource for financial information about Poniard Pharmaceuticals. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.
Recent Releases
Jun 5, 2009
Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
May 28, 2009
Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
more »
Events
Jun 10, 2009
8th Annual Needham Life Sciences Conference
May 31, 2009
Poniard Pharmaceuticals Investor Briefing
more »
|
Stock Information
PARD - (NASDAQ)
$6.68
+ 0.02
|
Jul 2, 2009
4:11 PM ET |
Quotes delayed at least 20 minutes. Information provided by eSignal.
|